|
Volumn 84, Issue 8, 1999, Pages 2700-2704
|
Use of vitamin K2 (menatetrenone) and 1,25-dihydroxyvitamin D3 in the prevention of bone loss induced by leuprolide
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CALCITRIOL;
LEUPRIN;
LEUPRORELIN;
MENATETRENONE;
DRUG DERIVATIVE;
FARNOQUINONE;
VITAMIN K GROUP;
AGED;
ARTICLE;
BONE ATROPHY;
BONE DENSITY;
BONE MINERALIZATION;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG MECHANISM;
ENDOMETRIOSIS;
ESTROGEN THERAPY;
FEMALE;
HORMONE DEFICIENCY;
HUMAN;
LEIOMYOMA;
OSSIFICATION;
OSTEOLYSIS;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
TREATMENT OUTCOME;
UTERUS;
ADULT;
DRUG EFFECT;
MIDDLE AGED;
ADULT;
BONE DENSITY;
BONE RESORPTION;
CALCITRIOL;
FEMALE;
HUMANS;
LEUPROLIDE;
MIDDLE AGED;
VITAMIN K;
VITAMIN K 2;
|
EID: 0033237708
PISSN: 0021972X
EISSN: None
Source Type: Journal
DOI: 10.1210/jc.84.8.2700 Document Type: Article |
Times cited : (40)
|
References (21)
|